Praxis Precision Medicines, Inc. Quarterly Operating Income (Loss) in USD from Q3 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Praxis Precision Medicines, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2019 to Q3 2024.
  • Praxis Precision Medicines, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$56.8M, a 123% decline year-over-year.
  • Praxis Precision Medicines, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$164M, a 17.1% decline year-over-year.
  • Praxis Precision Medicines, Inc. annual Operating Income (Loss) for 2023 was -$126M, a 41.2% increase from 2022.
  • Praxis Precision Medicines, Inc. annual Operating Income (Loss) for 2022 was -$215M, a 28.5% decline from 2021.
  • Praxis Precision Medicines, Inc. annual Operating Income (Loss) for 2021 was -$167M, a 170% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$164M -$56.8M -$31.3M -123% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 -$133M -$37.5M -$2.53M -7.23% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$130M -$41.9M -$3.8M -9.96% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$126M -$27.8M +$13.6M +32.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 -$140M -$25.5M +$18.8M +42.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 -$159M -$35M +$25.4M +42.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$184M -$38.1M +$30.8M +44.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$215M -$41.5M +$17.2M +29.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 -$232M -$44.3M +$483K +1.08% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$233M -$60.4M -$23.9M -65.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$209M -$68.8M -$41.4M -151% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$167M -$58.7M -$32.9M -128% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-07
Q3 2021 -$134M -$44.8M -$28.6M -176% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$106M -$36.5M -$24.9M -215% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$80.9M -$27.4M -$19M -224% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$62M -$25.7M Oct 1, 2020 Dec 31, 2020 10-K 2022-02-28
Q3 2020 -$16.2M -$5.56M -52.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 -$11.6M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$8.47M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q3 2019 -$10.7M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.